| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000008411 |
| Receipt No. | R000009895 |
| Official scientific title of the study | Biological effects of oral antimicrobial on systemic bacterial infection caused by full-mouth scaling and root planning: a randomized controlled clinical trial |
| Date of disclosure of the study information | 2012/07/12 |
| Last modified on | 2019/02/04 (Ver. 9) |
| Basic information | ||
| Official scientific title of the study | Biological effects of oral antimicrobial on systemic bacterial infection caused by full-mouth scaling and root planning: a randomized controlled clinical trial | |
| Title of the study (Brief title) | Biological effects of oral antimicrobial on systemic bacterial infection secondary to FM-SRP | |
| Region |
|
|
| Condition | ||
| Condition | Moderate to severe chronic periodontitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate microbiological, serological and clinical effects of oral antimicrobial on systemic bacterial infection secondary to full-mouth scaling and root planning. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Cytokine expression level in serum |
| Key secondary outcomes | Blood endotoxin level
Cytokine expression level in gingival crevicular fluid |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Test group
1. 30 patients 2. Patients take 2g of test drug, 3 days before full-mouth scaling and root planning. |
|
| Interventions/Control_2 | Control group
1. 30 patients 2. Patients receive full-mouth scaling and root planning as usual. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Moderate to severe chronic
periodontitis patients over the age of 30 years 2. Possessed a minimum of 20 teeth 3. Having at least 12 teeth with probing pocket depth (PPD) greater than 5 mm in a full-mouth. |
|||
| Key exclusion criteria | 1. Persons who had received scaling and
root planing within the previous 6 months. 2. Persons who had taken systemic antibiotics or anti-inflammatory drugs within 3 months before experiment. 3. Persons who had severe systemic diseases. 4. Persons who is known or suspected hypersensitivity or intolerance to macrolide antibiotic. 5. Smoker 6. Persons who is suspected of having aggressive periodontitis. |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Hiromasa Yoshie |
| Organization | Niigata University Graduate School of Medical and Dental Sciences |
| Division name | Division of Periodontology |
| Address | 2-5274 Gakkocho-Dori, Chuo-ku, Niigata, 951-8514 Japan |
| TEL | 0252272871 |
| yoshie@dent.niigata-u.ac.jp | |
| Public contact | |
| Name of contact person | Toshiya Morozumi |
| Organization | Niigata University Medical & Dental Hospital |
| Division name | Department of Periodontics |
| Address | 2-5274, Gakkocho-dori, Chuo-ku, Niigata, 951-8514, Japan |
| TEL | 0252272871 |
| Homepage URL | |
| moro@dent.niigata-u.ac.jp | |
| Sponsor | |
| Institute | Niigata University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Pfizer Japan Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Department of Periodontology, Tokyo Medical And Dental University
Department of Periodontics, Tsurumi University Bunkyo do-ri Dental Clinic Yoshino Dental Office Perio Implant Center |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 新潟大学医歯学総合病院(新潟県)
東京医科歯科大学歯学部附属病院(東京都) 鶴見大学歯学部附属病院(神奈川県) 文教通り歯科クリニック(千葉県) 吉野歯科診療所歯周病インプラントセンター(神奈川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009895 |